GlaxoSmithKline Spin-Off to Create Healthcare Giant Worth Estimated £40 Bil

...e business”. This was the case “particularly for its pharma business which has underperformed rivals such as (Covid-19 vaccine-maker) AstraZeneca over recent years”, he said. GSK is set to receive £7 billion in dividends...
Read Full Article